Maria Chiara Lionetti

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 20, 2025
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report.

Massimo Barberis, Alessandra Rappa, Filippo de Marinis

|Jun 22, 2023
Infiltration of tumor spheroids by activated immune cells.

Mrinmoy Mukherjee, Oleksandr Chepizhko, Maria Chiara Lionetti

|Aug 14, 2020
MicroRNA-222 Regulates Melanoma Plasticity.

Maria Chiara Lionetti, Filippo Cola, Oleksandr Chepizhko

Pageof 1

Frequent Collaborators

2 joint publications

Caterina A M La Porta

1 joint publications

Massimo Barberis

1 joint publications

Filippo de Marinis

1 joint publications

Giuseppe Pelosi

1 joint publications

Elena Guerini Rocco

1 joint publications

Yinxiu Zhan

1 joint publications

Maria Rita Fumagalli

1 joint publications

Roberto Ravasio

1 joint publications

Guido Tiana

1 joint publications

Mrinmoy Mukherjee

Frequent Collaborators

2 joint publications

Caterina A M La Porta

1 joint publications

Massimo Barberis

1 joint publications

Filippo de Marinis

1 joint publications

Giuseppe Pelosi

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.1K
A Macrophage-Tumor Spheroid Co-Invasion Assay
09:01

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on : Jan 24, 2025

658
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on : Jun 07, 2019

9.3K
See more related videos

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.1K
A Macrophage-Tumor Spheroid Co-Invasion Assay
09:01

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on : Jan 24, 2025

658
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on : Jun 07, 2019

9.3K
See more related videos